Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

“What we have to look at philosophically is what are the unmet needs of the Kingdom and how biotechnology can address that. This goes beyond vaccines or antibiotics or biosimilars; it actually relates ...